Acessibilidade / Reportar erro

New Method Improves the Assessment of Aortic Regurgitation Grade during TAVR by Aortography

Keywords
Transcatheter Aortic Valve Replacement/methods; Aortic Valve Insufficiency/mortality; Aortic Valve Insufficiency/diagnostic imaging; Echocardiography, Three-Dimensional/methods; Aortography/methods

Transcatheter aortic valve replacement (TAVR) is a rapidly expanding alternative to surgical aortic valve replacement for patients deemed inoperable or at high or intermediate operative risk. Yet, residual aortic regurgitation (AR) secondary to paravalvular leaks (PVL) remains a procedural limitation.11 Dahou A, Ribeiro HB, Rodes-Cabau J, Pibarot P. Impact and management of paravalvular regurgitation after transcatheter aortic valve replacement. Interv Cardiol Clin. 2015;4(1):67-82. Although residual AR after TAVR is frequent, affecting up to approximately 70% of the treated patients,22 Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60(19):1864-75.

3 Hahn RT, Pibarot P, Stewart WJ, Weissman NJ, Gopalakrishnan D, Keane MG, et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: A Longitudinal Study of Echocardiography Parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol. 2013;61(25):2514-21.
-44 Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585-95. it is moderate to severe in approximately 12% of these44 Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585-95. and steadily below 5% with current-generation devices, which come with specific sealing features.11 Dahou A, Ribeiro HB, Rodes-Cabau J, Pibarot P. Impact and management of paravalvular regurgitation after transcatheter aortic valve replacement. Interv Cardiol Clin. 2015;4(1):67-82. Noteworthy, moderate/severe AR has a detrimental clinical impact after TAVR, with a 3-fold increase in 30-day mortality and a 2.3-fold increase in 1-year mortality.44 Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585-95. Thus, its accurate assessment and quantification with a multimodality approach is key for appropriate utilization of additional procedures to reduce PVL, such as balloon post-dilatation (BPD), valve-in-valve, or leak closure.11 Dahou A, Ribeiro HB, Rodes-Cabau J, Pibarot P. Impact and management of paravalvular regurgitation after transcatheter aortic valve replacement. Interv Cardiol Clin. 2015;4(1):67-82.,55 Ribeiro HB, Orwat S, Hayek SS, Larose E, Babaliaros V, Dahou A, et al. Cardiovascular magnetic resonance to evaluate aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;68(6):577-85.

While Doppler echocardiography has been the most common method to assess AR following TAVR, its accurate quantification is challenging since AR jets are often multiple and eccentric.33 Hahn RT, Pibarot P, Stewart WJ, Weissman NJ, Gopalakrishnan D, Keane MG, et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: A Longitudinal Study of Echocardiography Parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol. 2013;61(25):2514-21.,55 Ribeiro HB, Orwat S, Hayek SS, Larose E, Babaliaros V, Dahou A, et al. Cardiovascular magnetic resonance to evaluate aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;68(6):577-85.

6 Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2009;22(9):975-1014.
-77 Ribeiro HB, Le Ven F, Larose E, Dahou A, Nombela-Franco L, Urena M, et al. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation. Heart. 2014;100(24):1924-32. Therefore, other methods for proper AR assessment have been evaluated in recent years, such as 3D echocardiography, hemodynamic AR index, aortography and even cardiovascular magnetic resonance, each one with its specific advantages and disadvantages.11 Dahou A, Ribeiro HB, Rodes-Cabau J, Pibarot P. Impact and management of paravalvular regurgitation after transcatheter aortic valve replacement. Interv Cardiol Clin. 2015;4(1):67-82.,55 Ribeiro HB, Orwat S, Hayek SS, Larose E, Babaliaros V, Dahou A, et al. Cardiovascular magnetic resonance to evaluate aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;68(6):577-85.,77 Ribeiro HB, Le Ven F, Larose E, Dahou A, Nombela-Franco L, Urena M, et al. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation. Heart. 2014;100(24):1924-32.

In the current issue of the journal, Miyazaki et al.88 Miyazaki Y, Modolo R, Abdelghani M, Tateishi H, Cavalcante R, Collet C, et al. Papel da avaliação aortográfica quantitativa da regurgitação aórtica por videodensitometria na orientação do implante da valva aórtica transcateter. Arq Bras Cardiol. 2018; 111(2):193-202. investigate a quantitative angiographic assessment of AR by videodensitometry (VD-AR) before and after BPD was performed. VD-AR was shown to decrease significantly from 24.0 [18.0-30.5] % to 12.0 [5.5-19.0] % (p < 0.001) after BPD, with some degree of AR grade improvement for up to 70% of patients treated. Of note, significant AR (VD-AR > 17%) was observed in 47 patients (77%) before and in 19 patients (31%) after BPD; moreover, in up to a quarter of these, pre-BPD VD-AR was below 17%, indicating that this additional maneuver could have been avoided. The study has its inherent limitations, e.g., the cohort was relatively small, with retrospective patient selection and imaging acquisition, and the decision whether or not to perform BPD was left to the discretion of the operators. Accordingly, the study only comprises cases where BPD was deemed necessary, and only aortograms with good quality imaging were selected.

Notably, the technique used to quantify VD-AR is a novel method that can accurately determine the regurgitation fraction in aortograms performed during TAVR; it uses dedicated software and showed excellent reproducibility and accuracy.99 Abdel-Wahab M, Abdelghani M, Miyazaki Y, Holy EW, Merten C, Zachow D, et al. A novel angiographic quantification of aortic regurgitation after TAVR provides an accurate estimation of regurgitation fraction derived from cardiac magnetic resonance imaging. JACC Cardiovasc Interv. 2018;11(3):287-97.,1010 Abdelghani M, Miyazaki Y, de Boer ES, Aben JP, van Sloun M, Suchecki T, et al. Videodensitometric quantification of paravalvular regurgitation of a transcatheter aortic valve: in vitro validation. EuroIntervention. 2018;13(13):1527-35. This technique provides an accurate assessment of the severity of PVL, and a VD-AR index greater than 17% correlated with increased mortality and with impaired cardiac reverse remodeling after TAVR.1111 Tateishi H, Campos CM, Abdelghani M, Leite RS, Mangione JA, Bary L, et al. Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry. EuroIntervention. 2016;11(12):1409-18.,1212 Abdelghani M, Tateishi H, Miyazaki Y, Cavalcante R, Soliman OI, Tijssen JG, et al. Angiographic assessment of aortic regurgitation by video-densitometry in the setting of TAVI: echocardiographic and clinical correlates. Catheter Cardiovasc Interv. 2017;90(4):650-9. And while VD-AR measurements are performed offline only, real-time online assessment is underway so as to enable this method to help guiding TAVR in the near future. After all, BPD is currently performed in about 10% to 20% of patients following TAVR, and it reduces the severity of PVL by at least one grade in more than two thirds of patients.1313 Nombela-Franco L, Barbosa Ribeiro H, Allende R, Urena M, Doyle D, Dumont E, et al. Role of balloon postdilation following trancatheter aortic valve implantation. Minerva Cardioangiol. 2013;61(5):499-512.,1414 Nombela-Franco L, Rodes-Cabau J, Delarochelliere R, Larose E, Doyle D, Villeneuve J, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5(5):499-512. Nevertheless, BPD may be associated with an increased risk of cerebrovascular events and annular trauma, therefore judicious utilization of this procedure is recommended.1313 Nombela-Franco L, Barbosa Ribeiro H, Allende R, Urena M, Doyle D, Dumont E, et al. Role of balloon postdilation following trancatheter aortic valve implantation. Minerva Cardioangiol. 2013;61(5):499-512.,1414 Nombela-Franco L, Rodes-Cabau J, Delarochelliere R, Larose E, Doyle D, Villeneuve J, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5(5):499-512.

In conclusion, since PVL has a negative impact on clinical outcomes after TAVR, its proper assessment through a multimodality, multiparametric, integrative approach is fundamental. Priority should be given to PVL prevention through accurate sizing of aortic annulus by 3D imaging techniques, THV devices with improved sealing features, and optimal THV sizing and positioning. Still, if PVL does occur after TAVR, the interventional cardiologist can consider corrective procedures such as BPD, valve-in-valve, or leak closure. The novel VD-AR after TAVR also allows quantitatively assessing post-TAVR regurgitation and may assist decision making on whether or not to perform BPD, as well as determining its efficacy. Future prospective studies are warranted to further confirm the present results.

References

  • 1
    Dahou A, Ribeiro HB, Rodes-Cabau J, Pibarot P. Impact and management of paravalvular regurgitation after transcatheter aortic valve replacement. Interv Cardiol Clin. 2015;4(1):67-82.
  • 2
    Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60(19):1864-75.
  • 3
    Hahn RT, Pibarot P, Stewart WJ, Weissman NJ, Gopalakrishnan D, Keane MG, et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: A Longitudinal Study of Echocardiography Parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol. 2013;61(25):2514-21.
  • 4
    Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585-95.
  • 5
    Ribeiro HB, Orwat S, Hayek SS, Larose E, Babaliaros V, Dahou A, et al. Cardiovascular magnetic resonance to evaluate aortic regurgitation after transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;68(6):577-85.
  • 6
    Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2009;22(9):975-1014.
  • 7
    Ribeiro HB, Le Ven F, Larose E, Dahou A, Nombela-Franco L, Urena M, et al. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation. Heart. 2014;100(24):1924-32.
  • 8
    Miyazaki Y, Modolo R, Abdelghani M, Tateishi H, Cavalcante R, Collet C, et al. Papel da avaliação aortográfica quantitativa da regurgitação aórtica por videodensitometria na orientação do implante da valva aórtica transcateter. Arq Bras Cardiol. 2018; 111(2):193-202.
  • 9
    Abdel-Wahab M, Abdelghani M, Miyazaki Y, Holy EW, Merten C, Zachow D, et al. A novel angiographic quantification of aortic regurgitation after TAVR provides an accurate estimation of regurgitation fraction derived from cardiac magnetic resonance imaging. JACC Cardiovasc Interv. 2018;11(3):287-97.
  • 10
    Abdelghani M, Miyazaki Y, de Boer ES, Aben JP, van Sloun M, Suchecki T, et al. Videodensitometric quantification of paravalvular regurgitation of a transcatheter aortic valve: in vitro validation. EuroIntervention. 2018;13(13):1527-35.
  • 11
    Tateishi H, Campos CM, Abdelghani M, Leite RS, Mangione JA, Bary L, et al. Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry. EuroIntervention. 2016;11(12):1409-18.
  • 12
    Abdelghani M, Tateishi H, Miyazaki Y, Cavalcante R, Soliman OI, Tijssen JG, et al. Angiographic assessment of aortic regurgitation by video-densitometry in the setting of TAVI: echocardiographic and clinical correlates. Catheter Cardiovasc Interv. 2017;90(4):650-9.
  • 13
    Nombela-Franco L, Barbosa Ribeiro H, Allende R, Urena M, Doyle D, Dumont E, et al. Role of balloon postdilation following trancatheter aortic valve implantation. Minerva Cardioangiol. 2013;61(5):499-512.
  • 14
    Nombela-Franco L, Rodes-Cabau J, Delarochelliere R, Larose E, Doyle D, Villeneuve J, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5(5):499-512.

Publication Dates

  • Publication in this collection
    Aug 2018
Sociedade Brasileira de Cardiologia - SBC Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil, Fax: +55 21 3478-2770 - São Paulo - SP - Brazil
E-mail: revista@cardiol.br